Back

Bruker Corporation

Ticker: BRKR ISIN: US1167941087
Add to portfolio Portfolio analysis in 2min
Stock Mid-cap Dividend payer Trading above 200-day average
Market cap
$8.00B
Forward P/E
23.75
Profit margin
-0.61%
Revenue growth QoQ
-0.50%
Div. yield
0.39%
Beta
1.17
$56.98 -4.33%
Price as of 2026-08-24 · NASDAQ

Performance by timeframe

Rolling returns
1 Month -5.11%
6 Months +43.62%
1 Year +65.45%
5 Years -7.93% p.a.-33.83%
10 Years +10.13% p.a.+162.18%
Since inception +5.27% p.a.+260.50%
Calendar year returns
YTD +21.24%
2025 -19.23%
2024 -19.99%
2023 +7.82%
2022 -18.29%
2021 +55.35%

Key stats

Market cap
8.00B
Dividend yield
0.39%
Beta
1.17
52-week range
28.46 - 64.32
50-day MA
44.41
200-day MA
39.13
Section 1

Business overview

Company profile data from fundamentals.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NASDAQ
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -1.09%
ROA 3.68%
Profit margin -0.61%
Operating margin 12.96%
PEG ratio 3.64
Revenue/share TTM 22.67
Revenue TTM 3.44B
EBITDA 585.00M
Gross profit TTM 1.68B
Beta 1.17

Valuation

Trailing P/E 0.00
Forward P/E 23.75
P/B 3.29
P/S 2.33
EV/EBITDA 33.55
EV/Revenue 2.83
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 1.88
Quarterly earnings growth 0.00%
Revenue TTM 3.44B
Reported quarters 102
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0.39%
Forward annual div. yield 0.38%
Dividend per share 0.2000
Payout ratio 11.56%
Ex-dividend date 2025-12-08
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $52.36
Analyst rating 3.8571

Ownership & short interest

Shares outstanding 151.94M
Shares float 103.31M
Institutional ownership 90.20%
Insider ownership 31.94%
Short ratio 4.88
Short % of float 16.29%

Details

Instrument metadata and source update timestamps.

Symbol BRKR
Name Bruker Corporation
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US1167941087
Country USA
Code + exchange BRKR.NASDAQ
Last price date 2026-01-06
Fundamentals updated 2026-01-07

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.